Broker s call: MAS Financial (Buy)
|
Updated on
CMP: ₹919.15
MAS Financials Ltd. (MAS) is a diversified financial services provider focused on low income groups and economically weaker individuals operating small businesses, as well as SMEs having limited access to formal financing channels.
Over the long-term, MAS’s AUM growth is likely to be driven by micro-enterprise and SME loans, given high level of under-penetration in both segments. MAS continues to remain cautious in its lending approach and extends credit only where it is due. With disbursements yet to reach pre-Covid levels, we believe growth is likely to pick-up from H2-FY22 .
Updated Feb 11, 2021 | 08:48 IST
Earnings Today: ACC, AllCargo, Ashok Leyland, Bosch, Coal India, CRISIL, Dishman Carbogen, GIC, Graphite, Gujarat Pipavav, HUDCO, ITC, KNR Constructions, MRF, Natco Pharma, NCC, NHPC, Oil India. Stocks to track in trade for February 11, 2021: Metropolis Healthcare, IGL, Aurobindo Pharma, Bata, Titan | Photo Credit: BCCL
Key Highlights
IOL Chemicals PAT up 17.14% at Rs114.8 crore on lower tax payout; revenues remain flat
JB Chemicals profits up 133% to RS 154 crore; revenue up 27.9% on good traction from pharma space
Metropolis Healthcare
Metropolis Healthcare reported a 9.84% growth in revenues for the December quarter to Rs 244.8 crore. The healthcare testing and diagnostic segment has gained importance in the post-COVID world and that is evident in the rising sales revenues for the quarter. The profit wa up 39.42% and came in at Rs 58.57cr on higher revenues.